331 related articles for article (PubMed ID: 34326607)
1. Liver dysfunction and SARS-CoV-2 infection.
Gracia-Ramos AE; Jaquez-Quintana JO; Contreras-Omaña R; Auron M
World J Gastroenterol; 2021 Jul; 27(26):3951-3970. PubMed ID: 34326607
[TBL] [Abstract][Full Text] [Related]
2. COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management.
Li P; Liu Y; Cheng Z; Yu X; Li Y
Biomed Pharmacother; 2022 Oct; 154():113568. PubMed ID: 36029543
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection in patients with a normal or abnormal liver.
Cabibbo G; Rizzo GEM; Stornello C; Craxì A
J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
[TBL] [Abstract][Full Text] [Related]
4. Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination.
Nevola R; Criscuolo L; Beccia D; Delle Femine A; Ruocco R; Imbriani S; Alfano M; Villani A; Russo A; Perillo P; Marfella R; Adinolfi LE; Sasso FC; Marrone A; Rinaldi L
World J Gastroenterol; 2023 Feb; 29(5):800-814. PubMed ID: 36816617
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and liver disease: mechanistic and clinical perspectives.
Marjot T; Webb GJ; Barritt AS; Moon AM; Stamataki Z; Wong VW; Barnes E
Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):348-364. PubMed ID: 33692570
[TBL] [Abstract][Full Text] [Related]
6. Review article: COVID-19 and liver disease-what we know on 1st May 2020.
Garrido I; Liberal R; Macedo G
Aliment Pharmacol Ther; 2020 Jul; 52(2):267-275. PubMed ID: 32402090
[TBL] [Abstract][Full Text] [Related]
7. COVID-19: a fatal case of acute liver failure associated with SARS-CoV-2 infection in pre-existing liver cirrhosis.
Ihlow J; Seelhoff A; Corman VM; Gruber AD; Dökel S; Meinhardt J; Radbruch H; Späth-Schwalbe E; Elezkurtaj S; Horst D; Herbst H
BMC Infect Dis; 2021 Sep; 21(1):901. PubMed ID: 34479499
[TBL] [Abstract][Full Text] [Related]
8. Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature.
Bucurica S; Ionita Radu F; Bucurica A; Socol C; Prodan I; Tudor I; Sirbu CA; Plesa FC; Jinga M
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676691
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea.
Lee YR; Kang MK; Song JE; Kim HJ; Kweon YO; Tak WY; Jang SY; Park JG; Lee C; Hwang JS; Jang BK; Suh JI; Chung WJ; Kim BS; Park SY
Clin Mol Hepatol; 2020 Oct; 26(4):562-576. PubMed ID: 33053932
[TBL] [Abstract][Full Text] [Related]
10. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
[TBL] [Abstract][Full Text] [Related]
11. Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care.
Saviano A; Wrensch F; Ghany MG; Baumert TF
Hepatology; 2021 Aug; 74(2):1088-1100. PubMed ID: 33332624
[TBL] [Abstract][Full Text] [Related]
12. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and liver injury: An ongoing challenge.
Papagiouvanni I; Kotoulas SC; Pataka A; Spyratos DG; Porpodis K; Boutou AK; Papagiouvannis G; Grigoriou I; Vettas C; Goulis I
World J Gastroenterol; 2023 Jan; 29(2):257-271. PubMed ID: 36687117
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and the liver: What do we know so far?
Nasa P; Alexander G
World J Hepatol; 2021 May; 13(5):522-532. PubMed ID: 34131467
[TBL] [Abstract][Full Text] [Related]
15. Management of COVID-19 patients with chronic liver diseases and liver transplants.
Hu X; Sun L; Guo Z; Wu C; Yu X; Li J
Ann Hepatol; 2022; 27(1):100653. PubMed ID: 34929350
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological mechanisms of liver injury in COVID-19.
Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M
Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346
[TBL] [Abstract][Full Text] [Related]
17. From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic.
Vitale G; Gitto S; Marra F; Morelli MC
Intern Emerg Med; 2022 Jan; 17(1):15-24. PubMed ID: 34245423
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
Ge J; Pletcher MJ; Lai JC;
Gastroenterology; 2021 Nov; 161(5):1487-1501.e5. PubMed ID: 34284037
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later.
Ekpanyapong S; Bunchorntavakul C; Reddy KR
J Viral Hepat; 2022 Jan; 29(1):4-20. PubMed ID: 34352133
[TBL] [Abstract][Full Text] [Related]
20. Impact of SARS CoV-2 /COVID-19 infection on the course of advanced chronic liver disease and hepatocellular carcinoma.
Pazgan-Simon M; Kucharska M; Górka-Dynysiewicz J; Simon K
Pharmacol Rep; 2022 Dec; 74(6):1306-1314. PubMed ID: 36394820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
